Observational studyBMC neurology2019

Use of glatiramer acetate between 2010-2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients.

Chiara Zecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.